IGHE and anaphylaxis: These patients, known as secondary MCAS, experience symptoms associated with MC activation due to the involvement of both IgE-mediated (such as food-, drug-, or Hymenoptera venom–induced anaphylaxis) and non-IgE-mediated (e.g., exercise) mechanisms.